<DOC>
	<DOC>NCT01688726</DOC>
	<brief_summary>The purpose of this study is to evaluate the repeated use of SYSTANE® BALANCE on stabilizing the tear film of dry eye patients with an unstable tear film.</brief_summary>
	<brief_title>Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Noncontact lens wearer; Symptomatology as defined by the Ocular Surface Disease Index (OSDI) questionnaire; Lipid deficiency; Best visual acuity of 6/9 or better in each eye; Willingness to adhere to the instructions set in the clinical protocol; Signature of the subject informed consent form; Other protocoldefined inclusion criteria may apply. Use of systemic medication which might produce dry eye side effects; Systemic disease which might produce dry eye side effects; Active or recent ocular inflammation or infection; Use of ocular medication; Significant ocular anomaly; Previous ocular surgery; Previous use of Restasis; Any medical condition that might be prejudicial to the study; Pregnant or lactating; Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Dry eye</keyword>
	<keyword>Ocular surface</keyword>
	<keyword>Vision complaint</keyword>
	<keyword>Tear film stability</keyword>
	<keyword>Time controlled functional visual acuity</keyword>
	<keyword>Tear film kinetics</keyword>
</DOC>